Top Markets
#1 Glidr Glidr +51.75%
#2 Akedo Akedo +50.81%
#3 DOVU DOVU +50.51%
#4 Cross Cross +49.17%
#5 Black Phoenix Black Phoenix +34.33%
#6 Velvet Velvet +32.01%
#7 OVERTAKE OVERTAKE +22.01%
#8 Cap Cap +17.55%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.87%
#10 Movement Movement +13.76%
Coin of the day
Glidr Glidr
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Lipidor AB (publ) Lipidor AB (publ)

Lipidor AB (publ)

LIPI
Kedudukan dalam Saham #39103
Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in... Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in 2009, specializes in developing medicinal products. Its core business centers on creating treatments for various skin conditions, including psoriasis, bacterial skin infections, and atopic dermatitis. The company's product pipeline includes AKP-01, which is currently in Phase III clinical trials for psoriasis, while other formulations like AKP-02 (also for psoriasis) and AKP-03 and AKP-07 (for eczema) are in earlier, preclinical development stages. Beyond its own drug candidates, Lipidor manufactures and supplies active pharmaceutical ingredients (APIs). These APIs are incorporated into products addressing a broad spectrum of therapeutic applications, such as managing psoriasis, microbial infections, inflammation, fungal issues, local pain relief, acne, wound healing, eczema, and migraines. Lipidor also caters to the animal health market, offering a line of spray-on skin care products for dogs, cats, and horses. Additionally, it develops consumer health items designed for purposes like antibacterial action, antiseptic care, moisturizing, disinfection, and treating acne and warts. In a key strategic alliance, Lipidor has partnered with Cannassure Therapeutics Ltd. This collaboration aims to advance topical medicinal cannabis products specifically formulated to alleviate skin inflammations and psoriatic lesions.
Harga Saham
$0.02243487
Disegerakkan terakhir: 2025-06-04
Modal Pasaran
$650.09K
Perubahan (1 hari)
0.39%
Perubahan (1 tahun)
0.00%
Negara
SE
Perdagangan Lipidor AB (publ) (LIPI)

Kategori

Healthcare
Nisbah P/E bagi Lipidor AB (publ) (LIPI)
Nisbah P/E pada August 2026 TTM: -6.74
Menurut laporan kewangan dan harga saham terkini Lipidor AB (publ), nisbah P/E semasa (TTM) ialah -6.74. Pada akhir 2023, syarikat mempunyai nisbah P/E sebanyak -1.27.
Sejarah nisbah P/E bagi Lipidor AB (publ) dari 2016 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
2026 (TTM) -6.74 1.05%
2024 -6.67 424.78%
2023 -1.27 146.20%
2022 -0.52 -95.36%
2021 -11.14 -45.54%
2020 -20.46 -15.06%
2019 -24.09 51.11%
2018 -15.94 -60.17%
2017 -40.02 60.31%
2016 -24.97 0.00%
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 40.73 -704.28%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 29.64 -539.71%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 123.01 -1,925.10%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 22.25 -430.10%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 36.58 -642.73%
US
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.